Abstract:Abstract Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the first committed step in the pentose phosphate pathway (PPP), which converts β-D-glucose-6-phosphate into D-glucono-1,5-lactone-6-phosphate, while concomitantly producing reducing equivalents in the form of NADPH. NADPH is a required cofactor in reductive biosynthesis,and is also required for the generation of reduced glutathione, the major antioxidant responsible for preventing reactive oxygen species (ROS) damage. Lysine acetylation is an evolutionarily conserved post-translational modification in the regulation of a wide range of cellular processes. Several recent acetylome proteomic studies have identified more than 2000 potential acetylation substrates. Among these identified acetylated proteins is G6PD, implicating a novel modulation of G6PD at the post-translational level. However, our knowledge of how acetylation regulates G6PD activity is limited. This study is directed toward to understand the molecular mechanism by which acetylation regulates G6PD function to regulate cellular redox state in response to oxidative stress. Here, we found that G6PD activity is negatively modulated by acetylation, and the major regulated site of acetylation in G6PD was mapped to K403, an evolutionarily conserved lysine residue. Site-specific genetic incorporation of Nε-acetyl-lysine into the position 403 of G6PD revealed that K403 acetylated G6PD is incapable to form active dimers and displays a complete loss in activity. Moreover, we found that the reversible acetylation of K403 is critical to modulate G6PD activity in response to different physiologic conditions, such as high glucose and oxidizing agents. Cytosolic SIRT2 deacetylated G6PD at K403, and greatly restored G6PD activity by inducing the formation of active dimers. Knockdown of endogenous G6PD led to higher cellular susceptibility to oxidant-induced cell death. Re-expression of wild-type G6PD, but not the acetylated mimic G6PDK403Q, could rescue cells from oxidative injury. Together these results uncover a previously unknown mechanism by which SIRT2 deacetylates and activates G6PD and thus protects cells against ROS damage. Citation Format: Yiping Wang, Lisha Zhou, Yuzheng Zhao, Shiwen Wang, Yi Yang, Dan Ye, Yue Xiong, Kun-Liang Guan. SIRT2 deacetylates and activates glucose-6-phosphate dehydrogenase (G6PD) to protect cells against oxidative stress. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5177. doi:10.1158/1538-7445.AM2013-5177 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells

Modulation of G6PD Affects Bladder Cancer Via ROS Accumulation and the AKT Pathway in Vitro.

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

S-Glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration

O-GlcNAcylation of G6PD Promotes the Pentose Phosphate Pathway and Tumor Growth

Glucose-6-Phosphate Dehydrogenase Deficiency Activates Endothelial Cell and Leukocyte Adhesion Mediated via the TGFβ/NADPH Oxidases/ROS Signaling Pathway

Recent findings in the regulation of G6PD and its role in diseases

G6PD maintains the VSMC synthetic phenotype and accelerates vascular neointimal hyperplasia by inhibiting the VDAC1–Bax-mediated mitochondrial apoptosis pathway

Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia

Regulation of G6PD Acetylation by SIRT2 and KAT9 Modulates NADPH Homeostasis and Cell Survival During Oxidative Stress

Abstract 5177: SIRT2 Deacetylates and Activates Glucose-6-phosphate Dehydrogenase (G6PD) to Protect Cells Against Oxidative Stress.

Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy.

Diabetes Impaired Ischemia-Induced PDGF (Platelet-Derived Growth Factor) Signaling Actions and Vessel Formation Through the Activation of Scr Homology 2-Containing Phosphatase-1

Pgc-1 Alpha Is A Key Regulator Of Glucose-Induced Proliferation And Migration In Vascular Smooth Muscle Cells

The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia

Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer

Glucose 6-P Dehydrogenase-An Antioxidant Enzyme with Regulatory Functions in Skeletal Muscle during Exercise

G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease

Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity

Hypoxic Activation of G6PD Controls the Expression of Genes Involved in the Pathogenesis of Pulmonary Hypertension Through the Regulation of DNA Methylation.

Endothelial PFKFB3 Plays a Critical Role in Angiogenesis.